Teladoc Health (NYSE:TDOC) Price Target Lowered to $12.00 at Oppenheimer

Teladoc Health (NYSE:TDOC) had its price objective decreased by equities researchers at Oppenheimer from $14.00 to $12.00 in a report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the health services provider’s stock. Oppenheimer’s price objective would indicate a potential upside of 17.47% from the stock’s previous close.

TDOC has been the topic of several other research reports. Barclays upped their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Deutsche Bank Aktiengesellschaft upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Royal Bank of Canada upped their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. Evercore ISI increased their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, TD Cowen lowered their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and a consensus price target of $11.97.

Teladoc Health Trading Up 0.7 %

NYSE TDOC traded up $0.08 on Friday, hitting $10.22. The company’s stock had a trading volume of 1,535,448 shares, compared to its average volume of 4,090,093. The company’s 50-day simple moving average is $9.99 and its 200 day simple moving average is $9.04. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $21.74. The firm has a market cap of $1.76 billion, a P/E ratio of -1.77 and a beta of 1.01. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The firm had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Research analysts predict that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.95% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently bought and sold shares of TDOC. Murphy Pohlad Asset Management LLC acquired a new stake in Teladoc Health during the fourth quarter worth about $458,000. Robeco Institutional Asset Management B.V. increased its holdings in Teladoc Health by 21.8% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider’s stock valued at $6,365,000 after buying an additional 125,111 shares in the last quarter. KBC Group NV grew its position in shares of Teladoc Health by 72.3% during the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after acquiring an additional 3,714 shares during the period. Westside Investment Management Inc. raised its holdings in Teladoc Health by 43.8% in the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after purchasing an additional 2,800 shares during the period. Finally, Nisa Investment Advisors LLC grew its holdings in Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after purchasing an additional 424,180 shares during the period. Institutional investors and hedge funds own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.